GlassScriptPhysician profile
Savannah Tran
NPI 1942823935
$2,275.26
in general payments reported to CMS, 2019-2025
15 companies · $276 in 2025
The $276 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $56.76 · 2023: $1,719 · 2024: $223 · 2025: $276.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,312 · Travel and Lodging: $907.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,311.90 |
| Travel and Lodging | $906.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,284.27 | 2023 | Axonics, Bulkamid |
| Abbvie INC. | $195.20 | 2023-2025 | |
| Procept Biorobotics Corporation | $194.27 | 2023 | Aquabeam Robotic System |
| Pfizer INC. | $117.91 | 2023-2025 | |
| Tolmar, INC. | $96.73 | 2023-2025 | Jatenzo, Eligard |
| Endo Pharmaceuticals INC. | $70.47 | 2022-2023 | Aveed, Xiaflex |
| Boston Scientific Corporation | $61.20 | 2023-2025 | Lithovue, Spaceoar Vue System - 10ml |
| Baxter Healthcare | $56.54 | 2023-2025 | Tisseel |
| Progenics Pharmaceuticals, INC. | $44.69 | 2024-2025 | |
| Teleflex LLC | $43.15 | 2022 | |
| Janssen Biotech, INC. | $29.98 | 2025 | Erleada |
| Astellas Pharma US INC | $24.53 | 2023 | Myrbetriq |
| Sumitomo Pharma America, INC. | $23.58 | 2025 | Gemtesa |
| Accord Healthcare, INC. | $19.41 | 2025 | |
| Intuitive Surgical, INC. | $13.33 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Savannah Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.